Unfolding complexities into solutions

Jodas is an enterprising pharmaceutical company on a mission to change the course of life-care through bold pursuits in science, integrating all our activities of research, development, manufacturing, marketing, and supply chain.

Our business focus evolves continuously with a customer-centered portfolio of high-quality, effective, affordable niche and technologically challenging products from specialty therapeutic segments.

We are a committed, responsible company with a pulse on the rapidly changing innovation to commercialization landscape that develops business with integrity to deliver sustainable value to our stakeholders, to society, and to us.

Jodas operations focus on four specialty therapeutic segments with uncompromising quality.

Our focused therapeutic segments are:

  • Anti Infectives (Injectables)
  • Anti Cancer (Injectables & Orals)
  • Contrast Media (Injectables)
  • Critical and General Care (Injectables)


Focus market EU, CIS, LATAM, Middle East, Brazil, Canada, Australia, New Zealand, South Africa and West Africa.
Focus therapies Anti-infectives, Oncology, Contrast Media, Critical Care
Countries present 25+
Product registrations 350+
Product filings 200+
Growth plans Entry into regulated markets